Litcius/Paper detail

Health Care Providers’ Testing Practices for Coccidioidomycosis and Histoplasmosis in Patients With Community-Acquired Pneumonia—United States, 2020

Kaitlin Benedict, Yiman Li, Noelle‐Angelique Molinari, Brendan R. Jackson

2021Open Forum Infectious Diseases25 citationsDOIOpen Access PDF

Abstract

Laboratory testing is required to distinguish coccidioidomycosis and histoplasmosis from other types of community-acquired pneumonia (CAP). In this nationwide survey of 1258 health care providers, only 3.7% reported frequently testing CAP patients for coccidioidomycosis and 2.8% for histoplasmosis. These diseases are likely underdiagnosed, and increased awareness is needed.

Topics & Concepts

HistoplasmosisMedicinePneumoniaCommunity-acquired pneumoniaHistoplasma capsulatumFamily medicineHealth careIntensive care medicineDermatologyInternal medicineEconomic growthEconomicsFungal Infections and StudiesAntifungal resistance and susceptibilityPneumocystis jirovecii pneumonia detection and treatment
Health Care Providers’ Testing Practices for Coccidioidomycosis and Histoplasmosis in Patients With Community-Acquired Pneumonia—United States, 2020 | Litcius